Consensus NICE Ltd.

Equities

NICE

IL0002730112

Market Closed - TEL AVIV STOCK EXCHANGE 07:24:08 2024-04-25 am EDT 5-day change 1st Jan Change
86,430 ILa -0.48% Intraday chart for NICE Ltd. -1.92% +19.21%

Evolution of the average Target Price on NICE Ltd.

Price target over the last 5 years

History of analyst recommendation changes

fccd5f5533046d41.71Z3slgoXd_wltcCyFErKwu-Bl-MabnL_GjFfY056aE.tSA60W5aOJuU9bZEjBVifX3qQQy_If2olRqxBcNpiOOOPTrzHxonmJTdmg~4516c127d72cf06df8f2779df2322665
DA Davidson Upgrades NICE to Buy From Neutral, Adjusts Price Target to $300 From $250 MT
Mizuho Ups Price Target on NICE to $300 From $244, Keeps Buy Rating MT
Barclays Raises NICE's Price Target to $320 From $283, Keeps Overweight Rating MT
Oppenheimer Raises NICE Price Target to $300 From $225, Maintains Outperform Rating MT
RBC Raises Price Target on NICE to $285 From $238, Keeps Outperform Rating MT
Wedbush Raises NICE's PT to $270 From $230 After 'Strong' Q4 2023 Results, Keeps Outperform Rating MT
Citigroup Adjusts NICE's Price Target to $334 From $283, Keeps Buy Rating MT
Morgan Stanley Raises Price Target on NICE to $260 From $220, Keeps Overweight Rating MT
Morgan Stanley Upgrades NICE to Overweight From Equalweight, Cuts Price Target to $220 From $225 MT
Oppenheimer Adjusts NICE Price Target to $225 From $250, Maintains Outperform Rating MT
Citigroup Adjusts NICE Price Target to $338 From $278, Maintains Buy Rating MT
William Blair Starts NICE at Outperform MT
Mizuho Initiates NICE at Buy With $244 Price Target MT
Jefferies Adjusts Price Target on NICE to $235 From $260, Keeps Buy Rating MT
Wedbush Cuts NICE's Price Target to $230 From $250 Reflecting Lower Multiple, Keeps Outperform Rating MT
Citigroup Adjusts Price Target on NICE to $278 From $277, Keeps Buy Rating MT
Piper Sandler Upgrades NICE to Overweight From Neutral, Adjusts Price Target to $227 From $222 MT
RBC Capital Adjusts Price Target on NICE to $238 From $265, Maintains Outperform Rating MT
Citigroup Adjusts Price Target on NICE to $260 From $254, Maintains Buy Rating MT
Morgan Stanley Adjusts NICE's Price Target to $215 from $235, Retains Equalweight Rating MT
Piper Sandler Starts NICE at Neutral With $236 Price Target MT
Wedbush Adjusts Price Target on NICE to $250 From $220, Citing Cloud Revenue, Keeps Outperform Rating MT
RBC Raises Price Target on NICE to $265 From $240, Citing 'Clean' Q2 With Margin Expansion, 2022 Guidance Boost; Outperform Kept MT
Barclays Adjusts Price Target on NICE to $283 From $356, Reiterates Overweight Rating MT
Morgan Stanley Adjusts NICE's Price Target to $235 From $260, Reiterates Equalweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
227.2 USD
Average target price
284.4 USD
Spread / Average Target
+25.20%
High Price Target
284.4 USD
Spread / Highest target
+25.20%
Low Price Target
284.4 USD
Spread / Lowest Target
+25.20%

Consensus detail

Consensus revision (last 18 months)

Analysts covering NICE Ltd.

DA Davidson
Mizuho Securities
Barclays
Oppenheimer
RBC Capital Markets
Wedbush
Citigroup
Morgan Stanley
William Blair & Co.
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings